| Literature DB >> 30123314 |
Fu-Yuan Zhu1,2, Mo-Xian Chen3,4, Neng-Hui Ye5, Wang-Min Qiao6, Bei Gao4, Wai-Ki Law6, Yuan Tian1, Dong Zhang6, Di Zhang4, Tie-Yuan Liu4, Qi-Juan Hu3, Yun-Ying Cao7, Ze-Zhuo Su8, Jianhua Zhang3,9, Ying-Gao Liu1.
Abstract
BACKGROUND: The next-generation sequencing (NGS) technology has greatly facilitated genomic and transcriptomic studies, contributing significantly in expanding the current knowledge on genome and transcriptome. However, the continually evolving variety of sequencing platforms, protocols and analytical pipelines has led the research community to focus on cross-platform evaluation and standardization. As a NGS pioneer in China, the Beijing Genomics Institute (BGI) has announced its own NGS platform designated as BGISEQ-500, since 2016. The capability of this platform in large-scale DNA sequencing and small RNA analysis has been already evaluated. However, the comparative performance of BGISEQ-500 platform in transcriptome analysis remains yet to be elucidated. The Illumina series, a leading sequencing platform in China's sequencing market, would be a preferable reference to evaluate new platforms.Entities:
Keywords: Alternative splicing; BGISEQ-500; Differential expressed genes; Illumina HiSeq4000; Next-generation sequencing; Transcriptome
Year: 2018 PMID: 30123314 PMCID: PMC6088413 DOI: 10.1186/s13007-018-0337-0
Source DB: PubMed Journal: Plant Methods ISSN: 1746-4811 Impact factor: 4.993
Fig. 1Schematic view of analytical pipeline of this study. SNP single nucleotide polymorphism, INDEL insertion–deletion, AS alternative splicing, DEG differentially expressed genes
Summary of basic parameters in three RNA sequencing datasets
| Sample | Total raw reads (Mb) | Total clean reads (Mb) | Genome mapped reads (Mb) | Gene mapped reads (Mb) | Genome mapping rate (%) | Gene mapping rate (%) | |
|---|---|---|---|---|---|---|---|
| HI-SEQ4000 | 1_DMSO_6 h_1 | 70.14 | 65.81 | 63.59 | 60.22 | 96.62 | 91.50 |
| 2_DMSO_6h_2 | 70.14 | 67.00 | 64.78 | 61.59 | 96.68 | 91.92 | |
| 3_DMSO_6h_3 | 70.14 | 65.54 | 63.09 | 59.47 | 96.26 | 90.74 | |
| 4_ABA_6h_1 | 70.14 | 66.44 | 63.52 | 59.48 | 95.60 | 89.53 | |
| 5_ABA_6h_2 | 70.14 | 67.02 | 64.72 | 61.60 | 96.57 | 91.92 | |
| 6_ABA_6h_3 | 70.14 | 66.86 | 64.46 | 60.82 | 96.41 | 90.97 | |
| BGI-SEQ500 | 1_DMSO_6h_1 | 72.10 | 67.00 | 65.44 | 61.19 | 97.67 | 91.33 |
| 2_DMSO_6h_2 | 69.63 | 65.85 | 64.53 | 63.06 | 97.99 | 95.77 | |
| 3_DMSO_6hJ_ | 69.62 | 65.80 | 64.14 | 62.02 | 97.47 | 94.25 | |
| 4_ABA_6h_1 | 69.57 | 65.99 | 64.69 | 62.97 | 98.03 | 95.42 | |
| 5_ABA_6h_2 | 69.57 | 65.78 | 64.63 | 63.13 | 98.25 | 95.97 | |
| 6_ABA_6h_3 | 69.64 | 65.47 | 64.16 | 62.75 | 98.00 | 95.85 | |
| BGI-SEQ500 | 1_DMSO_6h_1 | 69.50 | 67.80 | 65.76 | 63.39 | 96.99 | 93.50 |
| 2_DMSO_6h_2 | 69.69 | 67.79 | 65.49 | 63.25 | 96.60 | 93.31 | |
| 3_DMSO_6h_3 | 68.16 | 66.41 | 64.41 | 61.99 | 96.99 | 93.34 | |
| 4_ABA_6h_1 | 67.36 | 65.67 | 63.71 | 61.49 | 97.02 | 93.64 | |
| 5_ABA_6h_2 | 67.92 | 66.26 | 64.25 | 62.05 | 96.96 | 93.64 | |
| 6_ABA_6h_3 | 69.71 | 68.02 | 66.68 | 64.06 | 98.03 | 94.18 |
Fig. 2Comparison of sequencing quality among BGISEQ-500 PE75, BGISEQ-500 PE100 and HiSeq4000 PE100. a Base quality representation for clean reads and Q20. b Reads quality evaluation and mapping percentage. c Reads distribution along the relative position of genes
Fig. 3Repeatability of gene detection and quantification among three sequencing approaches. a Venn diagram representation of gene detection. Expression density distribution (b), boxplot gene expression graph (c), high and low abundance transcripts quantification (d) for all the replicates tested by three sequencing approaches in this study
Fig. 4Differentially expressed genes determination among three sequencing approaches. a Venn diagram representation of DEG calling in each sequencing approach. b Cross-platform comparison in DEG detection. c Pathway enrichment of each sequencing approach. Black, pathways enriched in all the three approaches; Red, pathways enriched in two approaches; Orange, pathways enriched in one approach. A, alpha-Linolenic acid metabolism; B, Anthocyanin biosynthesis; C, Biosynthesis of secondary metabolites; D, Biosynthesis of unsaturated fatty acids; E, Carotenoid biosynthesis; F, Cutin, suberine and wax biosynthesis; G, Flavonoid biosynthesis; H, Galactose metabolism; I, Glycerolipid metabolism; J, Indole alkaloid biosynthesis; K, Metabolic pathways; L, Other glycan degradation; M, Biosynthesis of secondary metabolites in phenylpropanoid pathway; N, Plant hormone signal transduction; O, Plant-pathogen interaction; P, Starch and sucrose metabolism; Q, Phenylpropanoid biosynthesis; R, Other terpenoid biosynthesis; S, Zeatin biosynthesis; T, MAPK signaling pathway; U, Peroxisome; V, Fatty acid metabolism; W, Pentose and glucuronate interconversions; X, Phenylalanine metabolism
Fig. 5Comparison of alternative spliced events identification. Venn diagrams representation of AS events identification in DMSO- (a) and ABA-treated (b) samples by each sequencing approach. Venn diagrams to represent c AS events in DMSO-treated and d ABA-treated samples. ATS alternative transcription start, APA alternative polyadenylation, AE5′ alternative 5′ splice site, AE3′ alternative 3′ splice site
Summary of SNP identification
| Sample | A–G | C–T | Transition | A–C | A–T | C–G | G–T | Transversion | Total | |
|---|---|---|---|---|---|---|---|---|---|---|
| HI-SEQ4000 | 1_DMSO_6h_1 | 264 | 158 | 422 | 84 | 84 | 57 | 71 | 296 | 718 |
| 2_DMSO_6h_2 | 284 | 186 | 470 | 67 | 74 | 52 | 47 | 240 | 710 | |
| 3_DMSO_6h_3 | 254 | 202 | 456 | 62 | 66 | 49 | 57 | 234 | 690 | |
| 4_ABA_6h_1 | 297 | 201 | 498 | 91 | 96 | 58 | 68 | 313 | 811 | |
| 5_ABA_6h_2 | 250 | 192 | 442 | 75 | 66 | 42 | 64 | 247 | 689 | |
| 6_ABA_6h 3 | 248 | 181 | 429 | 63 | 86 | 43 | 51 | 243 | 672 | |
| Average | 266 | 187 | 453 | 74 | 79 | 50 | 60 | 262 | 715 | |
| BGI-SEQ500 | 1_DMSO_6h_1 | 491 | 264 | 755 | 240 | 305 | 49 | 77 | 671 | 1426 |
| 2_DMSO_6h_2 | 342 | 177 | 519 | 178 | 244 | 38 | 48 | 508 | 1027 | |
| 3_DMSO_6h_3 | 460 | 223 | 683 | 323 | 411 | 40 | 67 | 841 | 1524 | |
| 4_ABA_6h_1 | 348 | 217 | 565 | 178 | 256 | 46 | 70 | 550 | 1115 | |
| 5_ABA_6h_2 | 324 | 211 | 535 | 165 | 209 | 41 | 47 | 462 | 997 | |
| 6_ABA_6h_3 | 308 | 200 | 508 | 150 | 189 | 31 | 41 | 411 | 919 | |
| Average | 379 | 215 | 594 | 206 | 269 | 41 | 58 | 574 | 1168 | |
| BGI-SEQ500 | 1_DMSO_6h_1 | 384 | 191 | 575 | 295 | 432 | 60 | 128 | 915 | 1490 |
| 2_DMSO_6h_2 | 381 | 223 | 604 | 239 | 378 | 64 | 120 | 801 | 1405 | |
| 3_DMSO_6h_3 | 394 | 191 | 585 | 251 | 362 | 59 | 126 | 798 | 1383 | |
| 4_ABA_6h_1 | 398 | 178 | 576 | 292 | 368 | 57 | 105 | 822 | 1398 | |
| 5_ABA_6h_2 | 349 | 182 | 531 | 210 | 303 | 48 | 90 | 651 | 1182 | |
| 6_ABA_6h_3 | 323 | 167 | 490 | 202 | 273 | 44 | 90 | 609 | 1099 | |
| Average | 372 | 189 | 560 | 248 | 353 | 55 | 110 | 766 | 1326 |
Summary of INDEL identification
| Sample name | Total number | Up2k | Exon | Intron | Down2k | Intergenic | |
|---|---|---|---|---|---|---|---|
| HI-SEQ4000 | 1_DMSO_6h_1 | 813 | 45 | 611 | 108 | 30 | 19 |
| 2_DMSO_6h_2 | 774 | 53 | 590 | 79 | 30 | 22 | |
| 3_DMSO_6h_3 | 736 | 41 | 561 | 94 | 25 | 15 | |
| 4_ABA_6h_1 | 893 | 48 | 675 | 128 | 28 | 14 | |
| 5_ABA_6h_2 | 776 | 43 | 589 | 105 | 24 | 15 | |
| 6_ABA_6h_3 | 820 | 40 | 618 | 123 | 31 | 8 | |
| Average | 802 | 45 | 607 | 106 | 28 | 16 | |
| BGI-SEQ500 | 1_DMSO_6h_1 | 2438 | 65 | 1905 | 403 | 46 | 19 |
| 2_DMSO_6h_2 | 2342 | 72 | 1879 | 329 | 41 | 21 | |
| 3_DMSO_6h_3 | 2395 | 71 | 1832 | 416 | 52 | 24 | |
| 4_ABA_6h_1 | 2382 | 61 | 1898 | 359 | 40 | 24 | |
| 5_ABA_6h_2 | 2128 | 61 | 1731 | 287 | 33 | 16 | |
| 6_ABA_6h_3 | 1999 | 61 | 1617 | 278 | 31 | 12 | |
| Average | 2281 | 65 | 1810 | 345 | 41 | 19 | |
| BGI-SEQ500 | 1_DMSO_6h_1 | 1834 | 65 | 1552 | 163 | 43 | 11 |
| 2_DMSO_6h_2 | 1459 | 59 | 1258 | 84 | 38 | 20 | |
| 3_DMSO_6h_3 | 2130 | 87 | 1789 | 175 | 54 | 25 | |
| 4_ABA_6h_1 | 1561 | 55 | 1318 | 131 | 42 | 15 | |
| 5_ABA_6h_2 | 1288 | 46 | 1125 | 68 | 33 | 16 | |
| 6_ABA_6h_3 | 1252 | 51 | 1094 | 67 | 28 | 12 | |
| Average | 1587 | 61 | 1356 | 115 | 40 | 17 |